Search results
Nordstrom Anniversary Sale 2024: The Best Beauty Exclusive Deals from La Mer, Oribe, NuFACE & More -...
E! Online· 3 days agoGet excited, girlies, because the Nordstrom Anniversary Sale is back. Not only does it pack in some...
The human side of the industrial metaverse | Computer Weekly
Computer Weekly· 3 days agoDespite the media and many investors being focused on artificial intelligence (AI) and generative AI, the industrial metaverse is still advancing and making inroads into companies’ daily operations ...
More than 100 footballers give their take on Messi vs Ronaldo
Daily Mail· 3 days ago'I really admire the career he [Messi] has had and from his side, he has already talked of the...
Editorial: Charleston should do more to celebrate, protect its recent past
The Post and Courier· 3 days agoWhile Charleston was among the nation's first cities to use zoning to preserve its most historic...
Olfactory ensheathing cell transplantation as a strategy for spinal cord repair—what can it achieve?...
Nature· 3 days agoNumerous lines of evidence from animal studies indicate that transplants of olfactory ensheathing cells—glial cells derived from the olfactory system—can promote functional recovery in the injured ...
Arista Properties breaks ground on rainforest-inspired Wadi Villas in Dubai
Gulf News· 3 days agoDubai's elite gather to witness landmark moment in luxury real estate
Britain's Largest Hydro-Electric Development - Nature
Nature· 3 days agoWhen the Water-Power Sources Committee presented its report in 1924, this portion of Scotland was defined as a place where there were possibilities of water-power development ...
Tapping into MAGE potential to develop next-generation cancer therapies
Nature· 3 days agoBiotech company APO-T is developing bispecific T cell engagers (BiTEs) that facilitate the attraction of immune effector cells exclusively to cancer sites by targeting cancer cell antigens known as melanoma-associated antigen A (MAGE-A) proteins.
Customized vectors for targeted drug delivery
Nature· 3 days agoThe delivery of therapeutics to target areas continues to be a challenge for drug developers. In the case of drugs developed for central nervous system (CNS) conditions such as Alzheimer disease ...
Glycostem launches pivotal oncology trial with evolved naked natural killer cells
Nature· 3 days agoGlycostem’s pivotal trial is planned to start in late 2020 and will involve five European countries, eight clinical trial centers and 33 patients with minimal residual disease (MRD) positive ...